[Pharmacological action of cultured calculus bovis]

By means of comparative pharmacological study, the main pharmacodynamics and toxicity of cultured calculus bovis and natural calculus bovis were compared under the same conditions. The results show that both drugs possess sedative, antispasmodic, antipyretic, antiinflammatory, cardiotonic and hypotensive effects, the strength of effect and toxicity being similar.

[125I]melatonin binding sites in membrane preparations of quail brain: characteristics and diurnal variations

The binding of [125I]melatonin, a labelled ligand of melatonin, to quail brain membrane preparations was studied. Kinetic studies indicated that the binding of [125I]melatonin to membrane preparations of quail brains collected at mid-light was time-dependent and reversible. The Kd value determined from kinetic analysis was 614 pmol/l, similar to the Kd 705 +/- 81 pmol/l obtained from saturation experiments. The [125I]melatonin binding sites in quail brain membrane had the following order of pharmacological affinities: melatonin greater than 6-chloromelatonin greater than N-acetylserotonin greater than 5-hydroxytryptamine much greater than 5-methoxytryptophol, tryptamine, L-tryptophan, 5-hydroxytryptophan, 5-hydroxyindole-3-acetic acid, 1-acetylindole-3-carboxaldehyde, 3-acetylindole. Compounds known to act on serotonergic, adrenergic or acetylcholinergic receptors were inactive as compared with melatonin. Our results demonstrated the presence of specific melatonin binding sites in the quail brain membrane preparations. In addition, saturation studies demonstrated that [125I]melatonin binding sites in quail brain membrane preparations were 42% higher at mid-light (39.6 +/- 2.2 fmol/mg protein) than at mid-dark (22.6 +/- 2.5 fmol/mg protein), with no significant variation in their binding affinities.

Binding characteristics, regional distribution and diurnal variation of [125I]-iodomelatonin binding sites in the chicken brain

The [125I]-iodomelatonin binding sites in chicken brain membrane preparations were studied. The binding of [125I]-iodomelatonin to the membrane preparations of chicken brain was rapid, stable, saturable, and reversible. The order of pharmacological affinities of [125I]-iodomelatonin binding sites in the chicken brain membrane preparations was: melatonin greater than 6-chloromelatonin greater than N-acetylserotonin greater than 5-hydroxytryptamine greater than tryptamine greater than 5-methoxytryptophol, much greater than 1-acetylindole-3-carboxaldehyde, 5-hydroxyindole-3-acetic acid, L-tryptophan, 5-hydroxytryptophan, 3-acetylindole. Compounds known to act on the receptor of norepinephrine or acetylcholine were inactive as compared to melatonin. Among the various brain regions studied, melatonin binding had maximal level in the hypothalamus, intermediate levels in the mid-brain, ponsmedulla, and telencephalon, and minimum level in the cerebellum. Subcellular fraction studies indicated that 40% of the binding was located in the mitochondrial fraction, 27% in the nuclear, 26% in the microsomal, and 6% in the cytosol fraction. Scatchard analysis of the membrane preparations revealed a dissociation constant (Kd) of 199.6 +/- 17 pM and a total number of binding sites (Bmax) of 16.6 +/- 0.75 fmol/mg protein at midlight. Thus, our results showed the presence of specific melatonin binding sites in the chicken brain membrane preparations. Saturation studies demonstrated that [125I]-iodomelatonin binding capacity in chicken brain membrane preparations were 40% greater at midlight (16.6 +/- 0.75 fmol/mg protein) than at middark (10.6 +/- 0.56 fmol/mg protein), with no significant variation in their binding affinities.

Reaction of rat liver DT-diaphorase (NAD(P)H:quinone acceptor reductase) with 5'-[p-(fluorosulfonyl)benzoyl]-adenosine

Rat liver DT-diaphorase is inactivated by 5'-[p-(fluorosulfonyl)benzoyl]adenosine (5'-FSBA), following pseudo-first-order kinetics. A double-reciprocal plot of 1/kobs versus 1/[5'-FSBA] yields a straight line with a positive y intercept, indicative of reversible binding of the inhibitor before an irreversible incorporation. The dissociation constant (Kd) for the initial reversible enzyme-inhibitor complex is estimated at 2.86 mM with k2 = 0.22 min-1 (at pH 7.5 and 25 degrees). A stoichiometry of 2 mol of 5'-FSBA bound/mol of enzyme (i.e., 1 mol of the inhibitor bound/mol of subunit), at 100% inactivation, was determined from inactivation kinetics and from incorporation studies using 5'-[p-(fluorosulfonyl)benzoyl]-[14C]-adenosine. The irreversible inactivation as well as the covalent incorporation could be completely prevented by the presence of NAD(P)H during the incubation. These results indicate that 5'-FSBA inactivated DT-diaphorase by occupying its NAD(P)H binding site. Reverse phase high pressure liquid chromatography of tryptic digests of [14C]5'-FSBA-labeled DT-diaphorase revealed one radioactive peak containing two comigrating peptides. They are 146I-T-T-G-G-S-G-S-M-Y155 and 262S-I-P-A-D-N-Q-I-K270. By comparison of these sequences to those of the nucleotide binding sites of several kinases and dehydrogenases, it is suggested that the peptide I-T-T-G-G-S-G-S-M-Y is the one modified by 5'-FSBA and would be predicted to be the region where the pyrophosphate group of NAD(P)H binds.

Structure-function relationship of NAD(P)H:quinone reductase: characterization of NH2-terminal blocking group and essential tyrosine and lysine residues

The amino terminal blocked peptide of rat liver NAD(P)H:quinone reductase (DT-diaphorase) was determined by amino acid sequence analysis and by mass spectrometry. The mature protein is composed of 273 amino acids and contains an acetylated amino terminus, which was not identified by previous cDNA analysis. The enzyme was inactivated by p-nitrobenzenesulfonyl fluoride (NBSF) or 2,4,6-trinitrobenzenesulfonate (TNBS) with pseudo-first-order kinetics. These studies suggest that essential tyrosine and lysine may be present in the active site of this enzyme. The NBSF inhibition was protected by 1-naphthol and 1-naphthylamine, but not by NAD+. However, TNBS inhibition was not prevented by the naphthalene derivatives or NAD+. Specific peptides labeled with NBSF or TNBS were isolated by high-performance liquid chromatography and were sequenced. These analyses revealed that the NBSF-labeled tyrosine resides in a predominantly hydrophobic region and TNBS-labeled lysine in a predominantly hydrophilic region.

Management and outcome of pyogenic vertebral osteomyelitis

A rational program of diagnosis and therapy can be recommended on the basis of the results in a series of 34 cases of pyogenic vertebral osteomyelitis. The diagnosis can be made on history, physical examination, sedimentation rate, bone scan and X-ray. Blood and urine cultures should be done and may be of value. Biopsy of the area confirms the diagnosis and establishes adequate and specific antibiotic therapy. Bed rest is needed to relieve the patient's initial discomfort and to prevent deformity. Immobilization is most important in those patients with greater than 50% vertebral destruction for the first 3 months in order to prevent deformity.